News
FDA halts new clinical trials seeking to send American cells to hostile labs for genetic engineering
The order comes as the Trump administration vows to bring transparency back to the United States' health industry.
This valuable study presents a novel approach to enhance the therapeutic potential of mesenchymal stromal cells (MSCs) by genetically modifying their glycogen synthesis pathway, resulting in increased ...
The global market for Hydrogen Fuel Cell Drone was valued at USD 41.2 Million in the year 2024 and is projected to reach a ...
"The salmon cancer meat is actually referred to by the FDA as 'cultured salmon cell material," the user said, adding that ...
Screwworm parasites primarily infect livestock, but human cases have risen in Central America after the pests escaped ...
Developmental and synthetic biologist Michael Levin redefines what life really is, how intelligence works, and what the ...
As the Food Standards Agency works to complete a ‘fully safety assessment’ of two lab-produced foods, which would allow them ...
A recent survey suggests that every hour people around the world discard 5.7 million toothpaste tubes, 570,000 cell phones ...
As industrial pollution increasingly strains India's water & soil ecosystem, Hyderabad-based KEP Engineering (KEP) is ...
The Senate Finance Committee’s version of the megabill — which aims to extend Trump’s 2017 tax cuts — would reverse language ...
Organs-on-a-chip are miniature devices that use human cells to mimic organs. Harvard bioengineer Donald Ingber and colleagues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results